ExcelMale.com
    • You have probably reached our site in your search for health and potency. Are you wondering who to trust with men’s health information in an online world full of scammers and deception? Well, you are in the right place!

      Welcome to ExcelMale.com, one of the largest and best moderated men’s health forums on the Internet focused on increasing health, potency and productivity in men. With over 13,000 members (as of April 2016) that include educated men, physicians, pharmacists, dietitians, exercise trainers, nutritional supplement experts, and other professionals in the field, ExcelMale is fast becoming a leader in the field. Our forum topics range from testosterone replacement therapy, Trimix injections use for ED, HCG use for better fertility and libido, estradiol management, thyroid function optimization, peptide information, exercise routines, best supplements for men, high protein diets, testosterone side effect management and much more. We also provide men’s health information via Interviews with experts, Videos, and webinars. Last but not least, our members share their reviews of hormone replacement clinics and doctors, compounding pharmacies, pharmaceutical products, supplements, and much more. Our great moderators review every post daily to detect spammers or abuse, so ExcelMale is a safe environment for all men. And since every man wants to help important women in their lives, we do not neglect female health information as we include a folder called “ExcelFemale” to post the latest on HRT in women.


      Search our content by typing your question here.

      Register here to join our community! Don’t be shy, ask questions by posting in any forum folder. We can help each other to regain our best selves!.


      Wishing you the greatest health,

      Nelson Vergel

      Founder


    • A Review of Testosterone CV Studies Based on Prescription Data

      Another paper in the Asian Review of Andrology reviews the studies of cardiovascular events that were based on analyzing prescription records. Each study is summarized and its weaknesses discussed. The conclusion is that most studies have found no link between TRT and cardiovascular events.

      In large database studies that included over 215 000 T-treated men, most studies did not find that T treatment was associated with increased risks for mortality or for MI, stroke, or thrombosis. However, given the limitations of observational data, the cardiovascular risks of T treatment will remain unclear until a large, prospective, randomized, double-blind, placebo-controlled trial is conducted that is specifically designed to examine the risk for CV events with T treatment. Until then, clinicians should follow established clinical guidelines for T replacement and review potential risks of treatment with patients, recognizing that risks might be greatest in the first several months after initiation of testosterone therapy.
      Full text of the article is online.

      This article was originally published in forum thread: A Review of Testosterone CV Studies Based on Prescription Data